Professor Ray Chan

So, do we really know: What is a comprehensive #cancer centre? What should we expect them to be, to do, & to do for & with others? Check out Part II of our work: mdpi.com/2072-6694/17/6… @theNCI @uicc @COSAoncology @EuropeanCancer @myESMO @ASCO @CancerCareMASCC @CancerAustralia

Nurse practitioners can now issue cause-of-death certificates and witness non-written health directions in the ACT. ACN calls on other jurisdictions to follow suit, and remove all unnecessary barriers preventing NPs from delivering holistic care #NursesAreTheSolution

A new research article from Shirley SW Tse, Henry CY Wong and colleagues looks at the cost-effectiveness of Mepitel Film for prevention of acute radiation dermatitis (ARD) in breast cancer, from a Canadian healthcare payer’s perspective. Read more here: link.springer.com/article/10.100…

For World Cancer Day, COSA and CNSA have released a joint position statement on the contribution of nurses to cancer survivorship care in Australia, with recommendations for strengthening survivorship care nationally. Read more bit.ly/4rpF3yD bit.ly/3M83qSk

On #WorldCancerDay we launch our joint @COSAoncology and @CNSA_ORG position statement on the vital contribution of nurses to cancer survivorship care: lnkd.in/gK9FRTwd This statement recognises nurses as central to coordinated, equitable, accessible + person-centred care.

🌟 We care about equity in survivorship care for all. 🌟 We work together so people can live well with & beyond cancer. This #WorldCancerDay, we stand #UnitedByUnique — placing people at the heart of care. #CancerSurvivorship #ResearchThatMatters #FlindersCancerSurvivorship

Researchers have found that repurposing a safe and affordable blood pressure medication may help prevent cancer-related cognitive impairment. NeuRA (Neuroscience Research Australia) PhD candidate, Delyse McCaffrey, led the study, ​‘Candesartan, an angiotensin receptor blocker, prevents cognitive impairment in female mice with mammary cancer’, which was published in @BrainBehavImm . “Up to 75% of cancer patients report cognitive symptoms, with around 30% experiencing persistent deficits that interfere with daily functioning and quality of life,” Ms McCaffrey said. “This can impact a person’s ability to think, learn, remember, or make decisions. Despite the profound economic and psychosocial burden, there are limited therapeutic options. "Cancer-related cognitive impairment is associated with a combination of factors, including neuroinflammation, oxidative stress, and blood-brain barrier dysfunction, with evidence suggesting dysregulation of the renin-angiotensin system (RAS), which modulates these processes. “A key advantage of candesartan is its ability to cross the blood – brain barrier and modulate neurobiological processes linked to cognitive decline in cancer, making it an attractive candidate for repurposing to prevent cancer-related cognitive impairment,” Dr Walker said. She worked alongside her supervisors Dr Adam K. Walker and Professor Cynthia Shannon Weickert, and in collaboration with Professor @rayychan at @Flinders University and Professor Janette Vardy @VardyJanette at the @Sydney_Uni. You can read the full article here - neura.edu.au/news-media/med… You can read the study here - sciencedirect.com/science/articl…

Our first article for 2026 - planning for ‘when’ and not ‘if’ we get cancer - through building accessible and high-quality survivorship care systems. Our analysis and call to action: authors.elsevier.com/a/1mNds8Z12ybX…

A new Clinical Practice Statement is now available from our Oncodermatology Study Group on the prevention and management of acute radiation dermatitis with Mepitel Film and Hydrofilm: link.springer.com/article/10.100… #SuppOnc

In this MASCC Short Talk, @rayychan shares some key highlights of the work presented at #MASCC25 around patient navigation. Watch now: vimeo.com/1138959256?sha… #SuppOnc

Don’t forget to submit your abstracts for #MASCC26! Visit our website to learn more, and be sure to get your abstract in by January 16 (or December 17 if you plan to apply for a Conference Scholarship). mascc.org/annualmeeting2… #SuppOnc #SurvOnc #GlobOnc #PallOnc #Oncology

@GPONursing Congratulations Annie

We are so proud of our founding board member Professor Annie Young! Many congratulations on your lifetime achievement award 🎉🎉🎉🎉🎉

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation geriatriconcology.net/article/S1879-… via @chitchadkitchen et al @lucypgeridoc @drol007

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation geriatriconcology.net/article/S1879-… @chitchadkitchen @rayychan @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier

🚨 New #OpenAccess article! We mapped the global maze of #GeriatricAssessment in #CancerCare 🧓👵 🔍 27 barriers & 17 strategies to GA implementation ✅ Telehealth, nurse-led models, policy advocacy & more 🛠️ Tool template + upcoming #DelphiStudy Read here 👉 lnkd.in/gzfFqX4m #GeriatricOncology #ImplementationScience #JGO #ResearchImpact 🙏 With @WilliamDale_MD, @rayychan, Seyi Agbejule, @LKasherman, Catherine Paterson, @AnnaMislang, @martine_puts, @kristenhaase, Jolyn Johal @survonc

@74chos @CancerCareMASCC @fumikochino Awwwww

@rayychan @CancerCareMASCC @fumikochino Their loss was our gain @rayychan !!

I was rejected by the Hong Kong educational system when I was 16. My score didn’t make the cut off to proceed to A-level (UK system). I then pursued education in Australia which changed my life #TweetYourRejection #medTwitter @CancerCareMASCC @fumikochino

@fumikochino @CancerCareMASCC So gracious! Same to you!

@rayychan @CancerCareMASCC I cannot imagine an oncology community without your vital contributions!!

Pleased to have @COSAoncology endorsement of the @CancerCareMASCC and @ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: onlinelibrary.wiley.com/doi/epdf/10.11…. In this editorial, we offer implementation and future optimal care considerations.

Congratulations to all new Supportive Care 2030 Movement Fellows @CancerCareMASCC #cancer #survonc #supponc

Thankful to Prof. Raymond Chan @rayychan for his generous insights during the mentorship session after my oral proffered paper at #MASCC25 His global perspective on 💰 financial toxicity in cancer care is a must-read 📖👇 📄 @JCOOP_ASCO: doi.org/10.1200/OP.24.…